Programme - Friday March 25th - CET time zone
Available Channels
1
2
08:15 - 09:15
1
Channel
Sponsored Satellite Symposium
08:15 - 09:15
2
Channel
ESCEO SYMPOSIUM
Multimodal multidisciplinary management of patients with moderate to severe pain in knee osteoarthritis: a need to meet patients expectancies
Chairpersons:
Cyrus Cooper
& Olivier Bruyère
- Introduction: Why do we need a multimodal multidisciplinary management of osteoarthritis
- Multimodal multicomponent approach using oral medications
- Multimodal multicomponent approach combining injectable and oral medications
- Conclusion
09:15 - 11:45
Scientific Session III
Chairpersons:
Jean-Yves Reginster
& Elaine Dennison
1
Channel
09:15
Meet-The-Expert Session
Which drugs do impact fracture healing?
1
Channel
09:45
Plenary Lecture 3
Added value of the new version of the FRAX® algorithm
1
Channel
10:15
Meet-The-Expert Session
Treatment of disorders of phosphate homeostasis
1
Channel
10:45
Plenary Lecture 4
Cross-talking between the immune system and the skeleton
1
Channel
11:15
Plenary Lecture 5
How long should we treat osteoporotic patients under sequential therapy?
09:15 - 10:15
2
Channel
IOF Educational Lecture
Challenges and opportunities in the bone field, an IOF perspective
12:00 - 13:30
1
Channel
Sponsored Satellite Symposium
12:00 - 13:30
2
Channel
Sponsored Satellite Symposium
13:30 - 16:00
Scientific Session IV
Chairpersons:
Claudia Campusano
& John A. Kanis
1
Channel
13:30
Plenary Lecture 6
Calcium or vitamin D: both or neither?
1
Channel
14:00
Meet-The-Expert Session
Assessment of quality of life in sarcopenia: an urgent issue
1
Channel
14:30
Meet-The-Expert Session
Role of registries in musculoskeletal management
1
Channel
15:00
Sponsored Meet-The-Expert Session
13:30 - 17:40
Scientific Session V
Chairpersons:
Stefania Maggi
& Andreas Kurth
2
Channel
13:30
Educational Lecture
- Post-fracture care: State of the Art?
2
Channel
14:20
Oral communication selected from abstracts
OC1: COMPARATIVE EFFECTIVENESS AND CARDIOVASCULAR SAFETY OF ABALOPARATIDE AND TERIPARATIDE IN POST-MENOPAUSAL WOMEN NEW TO ANABOLIC THERAPY: A US REAL-WORLD DATABASE STUDY
Presenting author:
Authors:
2
Channel
14:30
Oral communication selected from abstracts
OC2: USE OF ROMOSOZUMAB IN THOSE WHO EXPERIENCED AN ON-STUDY FRACTURE: RESULTS FROM THE RANDOMISED FRAME AND ARCH PHASE 3 TRIALS
Presenting author:
Authors:
2
Channel
14:40
Oral communication selected from abstracts
OC3: CONCOMITANT PPI USE NEGATES ORAL BISPHOSPHONATE ANTI-FRACTURE EFFICACY: A POST HOC ANALYSIS FROM A RANDOMIZED CONTROLLED TRIAL OF CLODRONATE
Presenting author:
Authors:
2
Channel
14:50
Oral communication selected from abstracts
OC4: FRACTURE RISK IN WOMEN WITH OSTEOPOROSIS TREATED WITH GASTRO-RESISTANT RISEDRONATE VERSUS IMMEDIATE RELEASE RISEDRONATE OR ALENDRONATE: A CLAIMS DATA ANALYSIS IN THE UNITED STATES
Presenting author:
Authors:
2
Channel
15:00
Sponsored Meet-The-Expert Session
2
Channel
16:00
Oral communication selected from abstracts
OC5: FRACTURES INCREASE EARLY AND LONG-TERM MORTALITY IN CANCER PATIENTS: A POPULATION-BASED COHORT STUDY
Presenting author:
Authors:
2
Channel
16:10
Oral communication selected from abstracts
OC6: IMPROVED FRACTURE RISK PREDICTION BY ADDING VFA-IDENTIFIED VERTEBRAL FRACTURE DATA TO BMD BY DXA AND CLINICAL RISK FACTORS USED IN FRAX
Presenting author:
Authors:
2
Channel
16:20
Oral communication selected from abstracts
OC7: MACHINE LEARNING AND COMPUTER VISION OF BONE MICROARCHITECTURE CAN IMPROVE THE FRACTURE RISK PREDICTION PROVIDED BY DXA AND CLINICAL RISK FACTORS
Presenting author:
Authors:
2
Channel
16:30
Oral communication selected from abstracts
OC8: PRIMARY HYPERPARATHYROIDISM, BONE MINERAL DENSITY AND INCIDENT FRACTURE RISK: A DANISH REGISTER STUDY
Presenting author:
Authors:
2
Channel
16:40
Meet-The-Expert Session
Management of tumoral bone disease
2
Channel
17:10
Oral communication selected from abstracts
OC9: VERTEBRAL FRACTURES ON ROUTINE CT SCANS PREDICT MAJOR OSTEOPOROTIC FRACTURES AND HIP FRACTURES: OBSERVATIONAL COHORT STUDY
Presenting author:
Authors:
2
Channel
17:20
Oral communication selected from abstracts
OC10: THE PROPORTION OF PATIENTS WHO REACH THE BMD SURROGATE THRESHOLD EFFECT ON ROMOSOZUMAB: A POST HOC ANALYSIS OF THE RANDOMISED FRAME AND ARCH PHASE 3 TRIALS
Presenting author:
Authors:
2
Channel
17:30
Oral communication selected from abstracts
OC11: RISK OF FALLS AND FRACTURES FOLLOWING THE INITIATION OF ANTI-HYPERTENSIVES IN THE ELDERLY: SELF-CONTROLLED CASE SERIES ANALYSES FROM THE UK
Presenting author:
Authors:
16:00 - 17:45
Scientific Session VI
Chairpersons:
Olivier Bruyère
& Patricia Clark
1
Channel
16:00
Plenary Lecture 7
Skeletal and extraskeletal effects of FGF23
1
Channel
16:30
Sponsored Meet-The-Expert Session
1
Channel
17:30
Awards Presentation
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award, the 2022 ESCEO Medal of Excellence
1
Channel
17:35
Award Presentation
Presentation of the ESCEO-AgNovos Healthcare Young Investigator Awards
1
Channel
17:40
Presentation of the ESCEO-IOF Young Investigator Awards